The effect of combined expression of interleukin 2 and interleukin 4 on the tumorigenicity and treatment of B16F10 melanoma
1996

Combined IL-2 and IL-4 Therapy for Melanoma

Sample size: 10 publication Evidence: moderate

Author Information

Author(s): SJ Hollingsworth, D Darling, J Giken, W Hirst, P Patel, M Kuiper, P Towner, S Humphreys, F Farzaneh, GJ Mufti

Primary Institution: King's College School of Medicine & Dentistry

Hypothesis

Does the combined expression of IL-2 and IL-4 reduce tumorigenicity in melanoma cells more effectively than either cytokine alone?

Conclusion

The combined expression of IL-2 and IL-4 significantly delays tumor formation and enhances immune response compared to individual cytokine treatments.

Supporting Evidence

  • Transduction with IL-2 or IL-4 alone delays tumor formation, but combined IL-2 + IL-4 is more effective.
  • Histological analysis showed increased immune cell infiltration in tumors expressing IL-2 + IL-4.
  • Treatment with irradiated cells expressing IL-2 + IL-4 led to systemic immunity in some cases.

Takeaway

Researchers found that using two special proteins, IL-2 and IL-4, together helps fight a type of skin cancer in mice better than using just one of them.

Methodology

The study involved transducing B16F10 melanoma cells with IL-2, IL-4, or both, and evaluating their tumorigenicity and immune response in mice.

Limitations

The study was conducted in rodent models, which may not fully replicate human responses.

Participant Demographics

C57B1/6 female mice, aged 6-8 weeks.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication